If you were at an investor event in May 2022 alongside alternative defense firm Axon, you might have spotted a rather unusual attendee: the softest of blonde hair, pacifier in place and no socks on their feet. This was Andrea James’ third child getting a fast-track induction to IR so that James could continue breastfeeding as she worked a high-profile, Street-facing job.
Today, James is finance lead at Oncocyte. But she isn’t just a CFO, nor just an IR Impact Award-winning former head of IR either. On her CV she proudly lists the position of . . .
Log in FOR FREE to access this content
Log in or create your free My IR – Essentials account to:
- Access 50+ deep dives and best practice reports
- View 100+ news analyses and our exclusive CFO series
- Instantly benchmark your IR program with our new tool
- Save favorites and get tailored content delivered to your dashboard
- 10% off all IR forums!
Join now to make a real impact in your organization.
